Extreme Lateral Interbody Fusion (XLIF) Surgery Market Report 2026

The extreme lateral interbody fusion (xlif) surgery market size has grown strongly in recent years. It will grow from $1.57 billion in 2025 to $1.66 billion in 2026 at a compound annual growth rate (CAGR) of 5.8%. The growth in the historic period can be attributed to increasing prevalence of degenerative disc disease, growth in spinal disorder cases, rising demand for minimally invasive surgery, improved surgical instrumentation, expansion of orthopedic hospitals.

The extreme lateral interbody fusion (xlif) surgery market size is expected to see strong growth in the next few years. It will grow to $2.05 billion in 2030 at a compound annual growth rate (CAGR) of 5.5%. The growth in the forecast period can be attributed to aging population growth, technological advancements in spinal implants, increasing surgeon preference for lateral approaches, rising healthcare infrastructure investments, growing awareness of minimally invasive spine surgery. Major trends in the forecast period include rising adoption of minimally invasive spine procedures, growing demand for faster post-surgical recovery, increased use of advanced interbody cages, expansion of specialized spine surgery centers, improved surgical outcomes through lateral access techniques.

The rising incidence of spinal illnesses is expected to drive the growth of the extreme lateral interbody fusion (XLIF) surgery market during the forecast period. Spinal illnesses encompass a variety of conditions affecting the spine, including its bones (vertebrae), discs, nerves, spinal cord, and surrounding muscles and ligaments. A major factor contributing to the increase in spinal illnesses is sedentary lifestyles, as prolonged sitting and limited physical activity can lead to poor posture and weakened core muscles, increasing the risk of spinal degeneration and chronic back pain. XLIF surgery is often required to address these spinal conditions, as it minimally invasively restores disc height and spinal alignment, relieves nerve compression, and stabilizes the spine without cutting through major back muscles. For instance, in June 2024, according to the Australian Institute of Health and Welfare, an Australia-based government agency, back problems had become the third leading cause of disease burden in the country by 2023, accounting for 4.3% of the total disease burden. Therefore, the rising incidence of spinal illnesses is propelling the growth of the XLIF surgery market.

Major companies in the XLIF surgery market are focusing on developing technologically advanced products, such as lateral plating systems, to reduce operative time and facilitate faster patient recovery. Lateral plating systems are orthopedic implants used in spine surgery to stabilize and support the vertebrae by attaching plates to the lateral aspect of the spine, often in conjunction with interbody fusion procedures, including XLIF. For instance, in August 2024, Globus Medical Inc., a US-based medical device manufacturer, launched the ADIRA XLIF Plate System. This system provides a streamlined lateral plating solution with a secure coupling mechanism that aligns plates over interbody spacers for enhanced stability. Compatible with bone screws and lateral MIS anchors, it supports various fixation methods and spacer types. Integrated with the Globus Medical lateral portfolio, it threads directly into multiple interbody spacers to reduce the risk of spacer movement and accommodate different patient needs and surgical preferences, improving both efficiency and reliability.

In September 2023, Globus Medical, a US-based medical device company, merged with NuVasive to form a global musculoskeletal company. The merger combines the strengths of both companies to offer one of the most comprehensive portfolios of musculoskeletal procedural solutions and enabling technologies, enhancing patient care across the entire treatment continuum. This strategic union brings together complementary global scale, an expanded commercial presence, and robust offerings in both spine and orthopedic segments. It also reinforces the companies’ shared commitment to innovation, surgeon education, and operational excellence. NuVasive is a US-based medical device company specializing in XLIF products and solutions.

Major companies operating in the extreme lateral interbody fusion (xlif) surgery market are Medtronic plc, Stryker Corporation, Zimmer Biomet Holdings Inc., NuVasive Inc., Globus Medical Inc., Orthofix Medical Inc., Alphatec Holdings Inc. (Alphatec Spine), Spinal Elements Inc., Surgalign Holdings Inc., Spineology Inc., CoreLink LLC, Aurora Spine Corporation, Life Spine Inc., Premia Spine Ltd., Nexxt Spine LLC, Spinal Simplicity LLC, CoreSpine Technologies LLC, NU-Spine LLC, ATEC Spine Inc., Captiva Spine Inc., Xtant Medical Holdings Inc., Centinel Spine LLC.

North America was the largest region in the extreme lateral interbody fusion (XLIF) surgery market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the extreme lateral interbody fusion (xlif) surgery market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the extreme lateral interbody fusion (xlif) surgery market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have impacted the extreme lateral interbody fusion (XLIF) surgery market by increasing the cost of imported interbody cages, titanium implants, neuromonitoring systems, and minimally invasive surgical tools. Hospitals and ambulatory surgical centers in Asia-Pacific and Latin America are most affected due to reliance on global orthopedic device suppliers. These higher costs can raise procedure prices and slow adoption of advanced XLIF techniques. However, tariffs are encouraging domestic manufacturing of implants and surgical systems, strengthening long-term supply security.

The extreme lateral interbody fusion (xlif) surgery market research report is one of a series of new reports that provides extreme lateral interbody fusion (xlif) surgery market statistics, including extreme lateral interbody fusion (xlif) surgery industry global market size, regional shares, competitors with a extreme lateral interbody fusion (xlif) surgery market share, detailed extreme lateral interbody fusion (xlif) surgery market segments, market trends and opportunities, and any further data you may need to thrive in the extreme lateral interbody fusion (xlif) surgery industry. This extreme lateral interbody fusion (xlif) surgery market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Extreme lateral interbody fusion (XLIF) surgery is a minimally invasive spinal fusion technique used to treat various spinal disorders. The procedure accesses the spine through a lateral (side) approach, avoiding major back muscles and reducing recovery time, while utilizing specialized surgical instruments and neuromonitoring for enhanced safety.

The main products for XLIF surgery include XLIF interbody fusion systems and XLIF interbody cages. These are used in procedures such as single-segment, multi-segment, and mini-open surgeries and are applied to conditions including spinal stenosis, herniated discs, and degenerative disc disease. End users of these products include hospitals, ambulatory surgical centers, and orthopedic clinics.

The extreme lateral interbody fusion (XLIF) surgery market consists of revenues earned by entities by providing services such as surgical training, intraoperative support, postoperative monitoring, reprocessing and sterilization services. The market value includes the value of related goods sold by the service provider or included within the service offering. The extreme lateral interbody fusion (XLIF) surgery market also includes sales of surgical access systems, fixation devices, neuromonitoring equipment and bone graft materials. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.